Diagnos, an international company that specialises in healthcare equipment, yesterday announced a new partnership with Garuda Health Services (GHS) to cover Cambodia.
Diagnos is considered a leader in early detection of critical health issues due to its popular AI-powered platform known as Flaire.
Garuda Capital Limited (GCL), a Hong Kong-based company, and its operational division GHS, is a private fund investing in cutting-edge technology in South Asia.
The company is also present in Vietnam and the Philippines.
GHS’s first customer in the kingdom will be Royal Phnom Penh Hospital, with a new eye screening service offered to patients as part of their annual physical check-ups.
The service is scheduled to be launched late this year and will cover 22,400 patients, according to a company statement.
“In adding eye screening with retina anomalies detection, we are increasing the number of health points to better determine the global health of our patients. This will significantly help us to prevent disease evolution and take early action,” a representative of Royal Phnom Penh Hospital said.
“As Diagnos is developing new algorithms to detect more illness, we will be ready to use them. Today, we take care of more than 22,400 expatriates living in Cambodia.
“We are proud to use Diagnos’ state-of-the-art technology and benefit from artificial intelligence in our daily fight against illnesses,” the statement adds.
“Diagnos and GHS can help other healthcare providers in the region to quickly deploy our CARA solution to enhance their screening by taking a picture of the retina,” said Yves-Stephane Couture, vice-president of sales at Diagnos.
“It’s inexpensive, quick, simple, non-invasive and it increases the overall value of regular health check-ups. We are at the forefront of a paradigm shift in establishing steps of early detection for preventive medicine,” said Mr Couture.
CARA is a tele-ophthalmology platform that integrates with existing equipment, hardware and software, and processes at the point of care (POC) and enables image upload, image enhancement automated pre-screening, grading by a specialist, and referral to a specialist.
“We are very happy to bring AI into Cambodia by partnering with Diagnos, a cutting-edge corporation in Canada where AI is already a reality. For GCL, the Royal Phnom Penh hospital is a good start to replicate the model in Vietnam and others countries,” said Frederic Proulx, managing partner at Garuda Capital Limited.